JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
LCTX Financials - Lineage Cell Therapeutics Income & Cash Flow | Ledgeburg
LCTX - Lineage Cell Therapeutics, Inc.
USD | NYSE | Healthcare
Summary
Summary LCTX Stock
Financials
Financials LCTX Stock
Loading...
Loading...
Income Statement
Income Statement LCTX Stock
Balance Sheet
Balance Sheet LCTX Stock
Cash Flow Statement
Cash Flow Statement LCTX Stock
Loading...
Loading...
Home
Stocks
Lineage Cell Therapeutics, Inc. (LCTX)
Financials
Financials of LCTX
Loading...
Loading...
Loading...
Loading...
Revenue
$14.556M
Operating Income
$-36.619M
Net Income
$-63.367M
Share Count (Basic)
230.116M
Operating Cash Flow
$-18.919M
Free Cash Flow
$-19.441M
Cash And Short-Term Equivalents
$55.781M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
5M
10M
15M
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
2M
4M
6M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-60M
-50M
-40M
-30M
-20M
Annual
Quarterly
Margins
Gross
Operating
Net
-1000%
-500%
0%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-30M
-20M
-10M
0
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-1000%
-800%
-600%
-400%
-200%
0%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26